Why QA Teams Are Choosing Atlas AI Copilot in 2025

If you run quality at a pharma or medical device company, 2025 is the year inspections got real again. The FDA is inspecting more facilities, posting 483s and EIRs faster, and pushing harder on quality systems. At the same time, QA teams are lean and timelines are tight. That's why teams are using the Atlas AI copilot: investigator-specific intelligence, faster prep, fewer surprises.

Below is what changed in 2025, why Atlas helps, and a step-by-step playbook to prepare for your assigned investigator.

What Changed in 2025

• Inspection volume is up. FY2025 saw 694 more FDA inspections than FY2024.
• Enforcement is accelerating. H2 2025 alone produced 327 warning letters, a 73% increase.
• Unannounced foreign inspections went global. Through May 2024, 94 of 114 FDA pilot inspections in India were unannounced. In May 2025, the FDA expanded this to a permanent global program.
• Inspection coverage is widening. Roughly 2,000 pharma manufacturers haven't been inspected since before COVID, and the FDA is catching up.
• 483 response expectations tightened. March 2026 FDA draft guidance raised the bar for 483 responses.

Shared ownership of inspection readiness between corporate quality and site quality matters more than ever.

Why Teams Are Choosing the Atlas AI Copilot

The Atlas AI copilot is built on a database of 700,000+ FDA inspections since 2010, 30,000+ Form 483s and EIRs, 11,800+ warning letters, and 6,000+ investigator reports. In plain terms, it helps you:

• Know your investigator before they arrive. Atlas surfaces that investigator's 483 history, CFR focus areas, and citation patterns so you know what they push on.
• See current trends. Spot spikes in cleaning validation or data integrity citations without hours of manual digging.
• Turn insights into action. The copilot converts focus areas into checklists, sample questions, and evidence lists.
• Benchmark against peers. Compare your SOPs and processes against peer inspection outcomes and recent 483 language.
• Assemble a Day-1 binder in minutes. Pull the documents investigators routinely ask for: org charts, training matrices, validation plans, CAPA logs, supplier status, utilities data.
• Draft smarter responses. Use recent, successful response patterns for similar observations.

What a Specific Investigator Usually Looks For

Every investigator has patterns. Some focus on data integrity and investigations. Others focus on cleaning validation, aseptic technique, or supplier controls. Atlas builds an investigator report showing:

• Top CFR sections they cite most often (for example, 211.100 process controls, 211.160 lab controls, 211.192 investigations, 211.67 cleaning, 211.25 training).
• Recent 483 excerpts that show how they phrase observations.
• Typical number of observations and common follow-up requests (raw data, audit trails, deviation trends).

How to run it: Open Atlas, choose USFDA Investigator in the search bar, type the investigator's name, and open the AI Copilot view. You'll see what the investigator usually looks for, their most common observations, and how to prepare for each.

What Major Areas Investigators Check During Inspections

Process controls and validation

• What they check: written procedures, change history, validation reports, in-process controls, excursions, trending.
• Records to have: validation protocols and reports, change-control logs, deviation trend reports, batch records.

Laboratory controls

• What they check: method validation, instrument suitability, reference standard control, sample records.
• Records to have: method validation reports, calibration certificates, sample logs, lab notebooks, raw chromatograms.

Investigations (OOS / OOT)

• What they check: completeness of investigations, original raw data, root cause analysis, effectiveness checks.
• Records to have: complete investigation decks, raw data files, CAPA plans and verification.

Cleaning and equipment

• What they check: cleaning validation, re-validation after change, equipment maintenance, cleaning records.
• Records to have: cleaning validation reports, swab or bioburden results, PM and calibration records.

Training and personnel

• What they check: training matrices, competency checks, observable operator technique (for sterile operations).
• Records to have: training records, competency test results, media fill performance for aseptic operations.

Data integrity and computerized systems (CSV)

• What they check: audit trails, electronic signatures, access control, backups, change logs.
• Records to have: audit trail extracts, user access lists, backup reports, system validation packages.

Supplier controls and supply chain

• What they check: supplier qualification, incoming material testing, certificates of analysis, audits.
• Records to have: supplier master list, audit reports, CoAs, incoming testing records.

Environmental monitoring (sterile and cleanrooms)

• What they check: trend data, excursions, corrective actions, gowning behavior.
• Records to have: EM trend charts, investigation reports, media fill results.

The Most Common Observations (and What Investigators Expect)

Incomplete or superficial OOS/OOT investigations

• Typical wording: "Failure to thoroughly investigate and document the cause of out-of-specification results, including raw data and meaningful root-cause analysis."
• Expect to show: raw data, full investigation report, root cause methodology, CAPA and verification.

Data integrity gaps (missing or altered raw data or audit trails)

• Typical wording: "Records do not provide a complete, attributable, and permanent raw data trail; audit trail missing or not available."
• Expect to show: unaltered raw data, audit trail exports, login and change logs.

Process validation not complete or not followed

• Typical wording: "Process validation documentation is incomplete or does not demonstrate control under routine manufacturing conditions."
• Expect to show: complete validation reports, re-validation after changes, documented acceptance criteria.

Inadequate laboratory method validation and controls

• Typical wording: "Laboratory methods are not properly validated or system suitability is not demonstrated for release testing."
• Expect to show: method validation reports, system suitability records, calibration logs.

Cleaning validation or sanitation program weaknesses

• Typical wording: "Cleaning validation studies are absent, incomplete, or the acceptance criteria are not defined."
• Expect to show: cleaning validation protocols and reports, swab results, acceptance criteria and justifications.

Training and competency shortfalls

• Typical wording: "Training records are incomplete or do not show competency for critical tasks."
• Expect to show: up-to-date training matrix, competency checks, on-the-job assessments.

CAPA program failures (ineffective or delayed corrective actions)

• Typical wording: "Corrective actions are not timely, are not linked to root cause, or effectiveness checks are missing."
• Expect to show: CAPA documentation, timelines, verification records.

Supplier qualification and incoming material control lapses

• Typical wording: "Supplier qualification documentation is incomplete or incoming material acceptance lacks scientific justification."
• Expect to show: supplier audit reports, CoAs, incoming test data, change history.

Change control not followed or not risk-assessed

• Typical wording: "Changes implemented without adequate risk assessment, validation, or approvals."
• Expect to show: change requests, risk assessments, impacted validation and testing.

Environmental monitoring excursions or aseptic deficiencies (sterile sites)

• Typical wording: "Environmental monitoring trends show excursions without thorough investigation or remediation."
• Expect to show: EM trend analysis, media fill reports, intervention logs, corrective actions.

Computerized system validation gaps

• Typical wording: "CSV documentation is incomplete; system user access or backup controls are inadequate."
• Expect to show: validation plans, test results, backup and restore logs, access control lists.

Labeling and packaging errors

• Typical wording: "Label reconciliation or packaging controls are not adequate to prevent mix-ups."
• Expect to show: label reconciliation records, packaging run records, complaint follow-up.

How QA Teams Can Proactively Prepare

Use this as a reusable playbook before every inspection.

Step 1. Run the Atlas investigator report

In the Atlas copilot, pull the investigator report and copy their top CFRs, top observations, and typical document requests.

Step 2. Map each top observation to real records at your site

For every observation on the list, map:

• Who owns the process (name and role)
• The SOPs or protocols that govern it
• Where the records live (physical shelf, network folder, LIMS location)
• Sample evidence the investigator will ask for

A simple spreadsheet works: Observation, Owner, Records to show, Location, Status.

Step 3. Run focused micro-audits

Use the investigator's likely questions (Atlas generates these) and request those exact documents internally. If anything is missing, log it as a pre-CAPA with owner and due date.

Step 4. Fix the quick wins immediately

• Close missing signatures and dates.
• Restore or export audit trails if missing.
• Update SOP headers and version control fields.
• Patch obvious housekeeping and labeling issues.

Step 5. Build your Day-1 evidence pack

Create a short folder (digital plus one printed index):

• Site overview, org chart, quality policy
• Validation master plan, recent validation and qualification reports
• Deviation and OOS trend summary with CAPA highlights
• Supplier list and recent audits
• CSV inventory and high-level validation status

Label it "Day-1 pack, for investigator requests."

Step 6. Rehearse roles and document flow

Assign host, scribe, document runners, and SME contacts. Run a 10-minute document request drill: request, locate, present, log.

Step 7. Day-of inspection behavior

Be factual and concise. Show the exact record requested. Avoid long narratives. If a record is missing, show the mitigation and the plan to fix. Keep a running log of what was shown and to whom.

Step 8. If a 483 appears

Acknowledge receipt professionally. Prepare a focused response that covers root cause, immediate containment, corrective action, timeframe, and how you will verify effectiveness. Remember: companies have 15 business days to respond.

Inspections got tougher in 2025. Atlas gives QA teams the intelligence to prepare for a specific investigator and the tools to rehearse before they arrive.

Atlas

See what the FDA knows about your next investigator.

30 minutes with the founder. No pitch deck.

See it live